» Articles » PMID: 28676116

Metabolic Syndrome and Its Predictors in an Urban Population in Kenya: A Cross Sectional Study

Overview
Publisher Biomed Central
Specialty Endocrinology
Date 2017 Jul 6
PMID 28676116
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The metabolic syndrome (MetS) is a clustering of interrelated risk factors which doubles the risk of cardio-vascular disease (CVD) in 5-10 years and increases the risk of type 2 diabetes 5 fold. The identification of modifiable CVD risk factors and predictors of MetS in an otherwise healthy population is necessary in order to identify individuals who may benefit from early interventions. We sought to determine the prevalence of MetS as defined by the harmonized criteria and its predictors in subjectively healthy black Africans from various urban centres in Kenya.

Method: We used data collected from healthy black Africans in Kenya as part of a global study on establishing reference intervals for common laboratory tests. We determined the prevalence of MetS and its components using the 2009 harmonized criterion. Receiver operator characteristic (ROC) curve analysis was used to determine the area under the curves (AUC) for various predictors of MetS. Youden index was used to determine optimum cut-offs for quantitative measurements such as waist circumference (WC).

Results: A total of 528 participants were included in the analysis. The prevalence of MetS was 25.6% (95% CI: 22.0%-29.5%). Among the surrogate markers of visceral adiposity, lipid accumulation product was the best predictor of MetS with an AUC of 0.880 while triglyceride was the best predictor among the lipid parameters with an AUC of 0.816 for all participants. The optimal WC cut-off for diagnosing MetS was 94 cm and 86 cm respectively for males and females.

Conclusions: The prevalence of MetS was high for a healthy population highlighting the fact that one can be physically healthy but have metabolic derangements indicative of an increased CVD risk. This is likely to result in an increase in the cases of CVD and type 2 diabetes in Kenya if interventions are not put in place to reverse this trend. We have also demonstrated the inappropriateness of the WC cut-off of 80 cm for black African women in Kenya when defining MetS and recommend adoption of 86 cm.

Citing Articles

Prevalence of metabolic syndrome and its association with selected factors among people with psychiatric conditions in Ethiopia: a systematic review and meta-analysis.

Tsega S, Alemayehu E, Dessie A, Anley D, Anteneh R, Moges N BMC Public Health. 2025; 25(1):744.

PMID: 39994655 PMC: 11849293. DOI: 10.1186/s12889-025-21571-4.


Determinants and prevalence of metabolic syndrome among the adult population in Hargeisa, Somaliland: A community-based cross-sectional study.

Ahmed A, Ahmed A, Abdilahi M, Nuh A PLoS One. 2024; 19(12):e0316094.

PMID: 39729496 PMC: 11676556. DOI: 10.1371/journal.pone.0316094.


Sociodemographic Factors Associated with Improved Metabolic Syndrome in Slum Dwelling Adults in Kenya: A Randomized Controlled Trial.

Okube O, Kimani S SAGE Open Nurs. 2024; 10:23779608241299647.

PMID: 39717025 PMC: 11664520. DOI: 10.1177/23779608241299647.


Frequency and Sex-Specific Associations of Metabolic Syndrome in Rwandans Seeking Outpatient Care: A Cross Sectional, Single Centre Study.

Gafirita J, Musarurwa C, Ntaganda E, Uwimana M, Hirwa A, Mukahigiro M Diabetes Metab Syndr Obes. 2024; 17:3803-3816.

PMID: 39434983 PMC: 11492906. DOI: 10.2147/DMSO.S477481.


Gender-specific accuracy of lipid accumulation product index for the screening of metabolic syndrome in general adults: a meta-analysis and comparative analysis with other adiposity indicators.

Witarto B, Witarto A, Visuddho V, Kencono Wungu C, Maimunah U, Rejeki P Lipids Health Dis. 2024; 23(1):198.

PMID: 38926783 PMC: 11201307. DOI: 10.1186/s12944-024-02190-1.


References
1.
Shah R, Murthy V, Abbasi S, Blankstein R, Kwong R, Goldfine A . Visceral adiposity and the risk of metabolic syndrome across body mass index: the MESA Study. JACC Cardiovasc Imaging. 2014; 7(12):1221-35. PMC: 4268163. DOI: 10.1016/j.jcmg.2014.07.017. View

2.
Wildman R, Muntner P, Reynolds K, McGinn A, Rajpathak S, Wylie-Rosett J . The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med. 2008; 168(15):1617-24. DOI: 10.1001/archinte.168.15.1617. View

3.
Kahn H . The "lipid accumulation product" performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison. BMC Cardiovasc Disord. 2005; 5:26. PMC: 1236917. DOI: 10.1186/1471-2261-5-26. View

4.
Lee D, Blomhoff R, Jacobs Jr D . Is serum gamma glutamyltransferase a marker of oxidative stress?. Free Radic Res. 2004; 38(6):535-9. DOI: 10.1080/10715760410001694026. View

5.
Varbo A, Benn M, Tybjaerg-Hansen A, Jorgensen A, Frikke-Schmidt R, Nordestgaard B . Remnant cholesterol as a causal risk factor for ischemic heart disease. J Am Coll Cardiol. 2012; 61(4):427-436. DOI: 10.1016/j.jacc.2012.08.1026. View